ポイントオブケアグルコース検査の世界市場2020-2026:製品種類別(ストリップ、ランセット・ランシングデバイス、メーター)、テストサイト別、エンドユーザー別、地域別

◆英語タイトル:Global Point-of-Care Glucose Testing Market Size study, by Product Type (Strips, Lancets & Lancing Devices, Meters), by Testing Site (Fingertip, Alternate Site Testing), by End-User (Professional Diagnostic Centers, Hospitals & Clinics, Home Care settings, Others) and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年4月25日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、ポイントオブケアグルコース検査の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品種類別(ストリップ、ランセット・ランシングデバイス、メーター)分析、テストサイト別分析、エンドユーザー別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・ポイントオブケアグルコース検査の世界市場:製品種類別(ストリップ、ランセット・ランシングデバイス、メーター)
・ポイントオブケアグルコース検査の世界市場:テストサイト別
・ポイントオブケアグルコース検査の世界市場:エンドユーザー別
・ポイントオブケアグルコース検査の世界市場:地域別
・競争状況
【レポートの概要】

Global Point-of-Care Glucose Testing Market is valued approximately at USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2020-2026. In recent years, the demand for point-of-care glucose testing has been witnessed significant growth. Point-of-care glucose testing helps in performing effective diagnosis at the patient’s bedside as compared to conventional laboratory testing. Point-of-care testing (POCT) for glucose monitoring is a valuable tool for supervising diabetic patients in outpatient settings. Further, point-of-care glucose testing devices and electronic medical records also allow sharing of test results instantly with healthcare providers. Potential operational benefits with reduced operating times, rapid decision-making capabilities, and high dependency strengthening the market growth of point-of-care glucose testing. Further, rise in the prevalence of diabetes, growing number of elderly population and increase in preference for home health care among people are the few factors responsible for high CAGR of the market over the forecast period. According to the International Diabetic Federation (IDF), the number of adults with diabetes was estimated around 415 million in 2015, and this number is projected to grow to almost 578 million by 2030, globally. Similarly, IDF also estimated that the number of diabetic patients in Europe is likely to rise from nearly 33 million in 2010 to 38 million in 2030. This, in turn, is expected to accelerate the demand for Point-of-Care Glucose Testing, thus contributing to the growth of the global market. However, accuracy issues in testing, stringent and time-consuming regulatory policies are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Point-of-Care Glucose Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging prevalence of diabetes and other lifestyle disorders, increase in number of product approvals and favorable government initiatives in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to growing healthcare facilities and favorable reimbursement policies in the countries like China and India.

Major market player included in this report are:
Roche Diabetes Care
LifeScan IP Holdings, LLC.
Abbott Laboratories
Ascensia Diabetes Care
Trividia Health, Inc.
Nova Biomedical
F. Hoffmann-La Roche Ltd.
Nipro Corporation
Prodigy Diabetes Care, LLC
EKF Diagnostics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Strips
Lancets & Lancing Devices
Meters

By Testing Site:
Fingertip
Alternate Site Testing

By End-User:
Professional Diagnostic Centers
Hospitals & Clinics
Home Care settings
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Point-of-Care Glucose Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Point-of-Care Glucose Testing Market, by Region, 2018-2026 (USD Million)
1.2.2. Point-of-Care Glucose Testing Market, by Product Type, 2018-2026 (USD Million)
1.2.3. Point-of-Care Glucose Testing Market, by Testing Site, 2018-2026 (USD Million)
1.2.4. Point-of-Care Glucose Testing Market, by End-User, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Point-of-Care Glucose Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Point-of-Care Glucose Testing Market Dynamics
3.1. Point-of-Care Glucose Testing Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Point-of-Care Glucose Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Point-of-Care Glucose Testing Market, by Product Type
5.1. Market Snapshot
5.2. Global Point-of-Care Glucose Testing Market by Product Type, Performance – Potential Analysis
5.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by Product Type 2016-2026 (USD Million)
5.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
5.4.1. Strips
5.4.2. Lancets & Lancing Devices
5.4.3. Meters
Chapter 6. Global Point-of-Care Glucose Testing Market, by Testing Site
6.1. Market Snapshot
6.2. Global Point-of-Care Glucose Testing Market by Testing Site, Performance – Potential Analysis
6.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by Testing Site 2016-2026 (USD Million)
6.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
6.4.1. Fingertip
6.4.2. Alternate Site Testing
Chapter 7. Global Point-of-Care Glucose Testing Market, by End-User
7.1. Market Snapshot
7.2. Global Point-of-Care Glucose Testing Market by End-User, Performance – Potential Analysis
7.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by End-User 2016-2026 (USD Million)
7.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
7.4.1. Professional Diagnostic Centers
7.4.2. Hospitals & Clinics
7.4.3. Home Care settings
7.4.4. Others
Chapter 8. Global Point-of-Care Glucose Testing Market, Regional Analysis
8.1. Point-of-Care Glucose Testing Market, Regional Market Snapshot
8.2. North America Point-of-Care Glucose Testing Market
8.2.1. U.S. Point-of-Care Glucose Testing Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Testing Site breakdown estimates & forecasts, 2016-2026
8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Point-of-Care Glucose Testing Market
8.3. Europe Point-of-Care Glucose Testing Market Snapshot
8.3.1. U.K. Point-of-Care Glucose Testing Market
8.3.2. Germany Point-of-Care Glucose Testing Market
8.3.3. Rest of Europe Point-of-Care Glucose Testing Market
8.4. Asia-Pacific Point-of-Care Glucose Testing Market Snapshot
8.4.1. China Point-of-Care Glucose Testing Market
8.4.2. India Point-of-Care Glucose Testing Market
8.4.3. Japan Point-of-Care Glucose Testing Market
8.4.4. Rest of Asia Pacific Point-of-Care Glucose Testing Market
8.5. Latin America Point-of-Care Glucose Testing Market Snapshot
8.5.1. Brazil Point-of-Care Glucose Testing Market
8.5.2. Mexico Point-of-Care Glucose Testing Market
8.6. Rest of The World Point-of-Care Glucose Testing Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Roche Diabetes Care
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. LifeScan IP Holdings, LLC.
9.2.3. Abbott Laboratories
9.2.4. Ascensia Diabetes Care
9.2.5. Trividia Health, Inc.
9.2.6. Nova Biomedical
9.2.7. F. Hoffmann-La Roche Ltd.
9.2.8. Nipro Corporation
9.2.9. Prodigy Diabetes Care, LLC
9.2.10. EKF Diagnostics
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET
TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2016-2026 (USD MILLION)
TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY TESTING SITE 2016-2026 (USD MILLION)
TABLE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
TABLE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 22. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 25. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 28. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 31. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 34. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 36. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 37. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 40. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 42. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 43. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 45. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 46. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 48. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 49. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 51. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 54. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 57. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ポイントオブケアグルコース検査の世界市場2020-2026:製品種類別(ストリップ、ランセット・ランシングデバイス、メーター)、テストサイト別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆